Omada Health CFO exercises options and sells shares

Q: What did OMDA CFO Steven L. Cook report in this Form 4?

OMDA CFO Steven L. Cook exercised stock options for 16,842 shares and sold 16,842 common shares in transactions dated August 10–11, 2026, according to the insider trading report.

Q: How many Omada Health (OMDA) shares did the CFO sell and at what prices?

The CFO sold 16,842 shares of Omada Health common stock at weighted average prices of about $25.03 and $25.01 per share, executed in multiple trades within narrow price ranges around $25.

Q: What option exercise prices did the OMDA CFO have in this filing?

The reported option exercises covered 16,842 shares at exercise prices of $8.28, $8.01, and $7.68 per share, converting stock options into Omada Health common stock before the related sales.

Q: What are the vesting terms of the Omada Health (OMDA) options in this report?

One option grant is 100% vested and exercisable, while two others vest at 1/48th of the shares monthly from February 1, 2024 and February 1, 2025, becoming fully vested after four years.

Omada Health, Inc. Chief Financial Officer Steven L. Cook reported option exercises and related share sales in mid-August 2026.

Filing Impact

(Neutral)

Filing Sentiment

(Neutral)How Sentiment works

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

How Sentiment works How the balance works

Form Type

Rhea-AI Filing Summary

Omada Health, Inc. Chief Financial Officer Steven L. Cook reported option exercises and related share sales in mid-August 2026. He exercised stock options covering 16,842 shares of common stock at exercise prices between $7.68 and $8.28 per share and sold the same total number of shares at weighted average prices around $25 per share. The transactions were made pursuant to a Rule 10b5-1 trading plan adopted on March 14, 2026, and include both fully vested options and options vesting monthly over four years.

Insider Trade Summary 10b5-1

Exercise and Sale: 16,842 shares ($283K approx. pre-tax spread)

Exercise and Sale 10 txns

Insider Cook Steven L.

Role Chief Financial Officer

Sold 16,842 shs ($422K)

Approx. gross sale proceeds $422K

Approx. exercise cost $139K

Approx. pre-tax spread $283K

Type	Security	Shares	Price	Value
Exercise	Stock Option (Right to Buy) ^{F1, F4}	1,607	$0.00	$0.00
Exercise	Common Stock ^F1	1,607	$8.28	$13K
Sale	Common Stock ^{F1, F3}	1,607	$25.0135	$40K
Exercise	Stock Option (Right to Buy) ^{F1, F4}	13,499	$0.00	$0.00
Exercise	Stock Option (Right to Buy) ^{F1, F5}	1,042	$0.00	$0.00
Exercise	Stock Option (Right to Buy) ^{F1, F6}	694	$0.00	$0.00
Exercise	Common Stock ^F1	13,499	$8.28	$112K
Exercise	Common Stock ^F1	1,042	$8.01	$8K
Exercise	Common Stock ^F1	694	$7.68	$5K
Sale	Common Stock ^{F1, F2}	15,235	$25.0312	$381K

Holdings After Transaction: Stock Option (Right to Buy) — 274,173 contracts (Direct); Common Stock — 187,209 shares (Direct)

Footnotes (6)

F1. Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on March 14, 2026.
F2. This transaction was executed in multiple trades at prices ranging from $25.00 to $25.13. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
F3. This transaction was executed in multiple trades at prices ranging from $25.00 to $25.05. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
F4. 100% of the shares subject to the option are fully vested and exercisable.
F5. 1/48th of the shares subject to the option vest on each monthly anniversary measured from February 1, 2024 (the "Vesting Commencement Date"), such that 100% of the shares subject to the option will be fully vested and exercisable on the fourth anniversary of the Vesting Commencement Date.
F6. 1/48th of the shares subject to the option vest on each monthly anniversary measured from February 1, 2025 (the "Vesting Commencement Date"), such that 100% of the shares subject to the option will be fully vested and exercisable on the fourth anniversary of the Vesting Commencement Date.

Key Figures

Shares sold: 16,842 shares Shares exercised: 16,842 shares Sale price (Aug 10): $25.0312 per share +5 more

8 metrics

Shares sold 16,842 shares Total common shares sold in code S transactions on August 10–11, 2026

Shares exercised 16,842 shares Total underlying shares from option exercises (code M) converting into common stock

Sale price (Aug 10) $25.0312 per share Weighted average price for 15,235-share sale on August 10, 2026

Sale price (Aug 11) $25.0135 per share Weighted average price for 1,607-share sale on August 11, 2026

Option exercise price $8.28 per share Exercise price for 13,499 and 1,607 option shares expiring July 19, 2031

Option exercise price $8.01 per share Exercise price for 1,042 option shares expiring February 8, 2034

Option exercise price $7.68 per share Exercise price for 694 option shares expiring January 27, 2035

10b5-1 plan adoption date March 14, 2026 Date the reporting person adopted the Rule 10b5-1 trading plan

Key Terms

Rule 10b5-1 trading plan, Stock Option (Right to Buy), weighted average price, vesting commencement date, +1 more

5 terms

Rule 10b5-1 trading plan regulatory

"Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person"

A Rule 10b5-1 trading plan is a pre-arranged schedule that allows company insiders to buy or sell stock at specific times, even if they have inside information. It helps prevent accusations of unfair trading by making these transactions look planned and transparent, rather than sneaky or illegal.

Stock Option (Right to Buy) financial

"security_title: Stock Option (Right to Buy) with underlying Common Stock shares"

weighted average price financial

"The price reported above reflects the weighted average price"

Weighted average price is the average price of a security where each trade or component is counted according to its size, so bigger trades pull the average more than smaller ones. Think of it like calculating the average cost of a grocery haul where items you bought more of have greater influence on the final per-item cost. Investors use it to understand the true average price paid or received, judge execution quality, and compare trading performance against market movement.

vesting commencement date financial

"measured from February 1, 2024 (the "Vesting Commencement Date")"

The vesting commencement date is the starting point when an employee begins earning ownership rights to their promised benefits, such as stock options or retirement contributions. Think of it like the day a savings account is opened—only after this date do the benefits start to grow and become fully available over time. It matters to investors because it marks when the clock begins ticking toward full ownership, affecting the timing and value of these benefits.

fully vested and exercisable financial

"100% of the shares subject to the option are fully vested and exercisable"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What did OMDA CFO Steven L. Cook report in this Form 4?

OMDA CFO Steven L. Cook exercised stock options for 16,842 shares and sold 16,842 common shares in transactions dated August 10–11, 2026, according to the insider trading report.

How many Omada Health (OMDA) shares did the CFO sell and at what prices?

The CFO sold 16,842 shares of Omada Health common stock at weighted average prices of about $25.03 and $25.01 per share, executed in multiple trades within narrow price ranges around $25.

What option exercise prices did the OMDA CFO have in this filing?

The reported option exercises covered 16,842 shares at exercise prices of $8.28, $8.01, and $7.68 per share, converting stock options into Omada Health common stock before the related sales.

Were the OMDA CFO’s transactions under a Rule 10b5-1 trading plan?

Yes. A footnote states the transactions were made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 14, 2026, indicating they were pre-arranged under that plan.

What are the vesting terms of the Omada Health (OMDA) options in this report?

One option grant is 100% vested and exercisable, while two others vest at 1/48th of the shares monthly from February 1, 2024 and February 1, 2025, becoming fully vested after four years.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google

Accepted by SEC EDGAR 08/12/2026 - 04:48 PM EDT

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Cook Steven L.

(Last)

(First)

(Middle)

C/O OMADA HEALTH, INC.

611 GATEWAY BLVD, SUITE 120

(Street)

SOUTH SAN FRANCISCO

CALIFORNIA

94080

(City)

(State)

(Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Omada Health, Inc. [ OMDA ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director	10% Owner
X	Officer (give title below)	Other (specify below)
	Chief Financial Officer

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
08/10/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
Common Stock	08/10/2026		M⁽¹⁾		13,499	A	$8.28	200,708	D
Common Stock	08/10/2026		M⁽¹⁾		1,042	A	$8.01	201,750	D
Common Stock	08/10/2026		M⁽¹⁾		694	A	$7.68	202,444	D
Common Stock	08/10/2026		S⁽¹⁾		15,235	D	$25.0312⁽²⁾	187,209	D
Common Stock	08/11/2026		M⁽¹⁾		1,607	A	$8.28	188,816	D
Common Stock	08/11/2026		S⁽¹⁾		1,607	D	$25.0135⁽³⁾	187,209	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
Stock Option (Right to Buy)	$8.28	08/10/2026		M⁽¹⁾			13,499	⁽⁴⁾	07/19/2031	Common Stock	13,499	$0	236,196	D
Stock Option (Right to Buy)	$8.01	08/10/2026		M⁽¹⁾			1,042	⁽⁵⁾	02/08/2034	Common Stock	1,042	$0	18,750	D
Stock Option (Right to Buy)	$7.68	08/10/2026		M⁽¹⁾			694	⁽⁶⁾	01/27/2035	Common Stock	694	$0	20,834	D
Stock Option (Right to Buy)	$8.28	08/11/2026		M⁽¹⁾			1,607	⁽⁴⁾	07/19/2031	Common Stock	1,607	$0	234,589	D

Explanation of Responses:

1. Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on March 14, 2026.

2. This transaction was executed in multiple trades at prices ranging from $25.00 to $25.13. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

3. This transaction was executed in multiple trades at prices ranging from $25.00 to $25.05. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

4. 100% of the shares subject to the option are fully vested and exercisable.

5. 1/48th of the shares subject to the option vest on each monthly anniversary measured from February 1, 2024 (the "Vesting Commencement Date"), such that 100% of the shares subject to the option will be fully vested and exercisable on the fourth anniversary of the Vesting Commencement Date.

6. 1/48th of the shares subject to the option vest on each monthly anniversary measured from February 1, 2025 (the "Vesting Commencement Date"), such that 100% of the shares subject to the option will be fully vested and exercisable on the fourth anniversary of the Vesting Commencement Date.

	/s/ Nathan Salha, as Attorney-in-Fact for Steven L. Cook	08/12/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Source: View Original Filing on SEC EDGAR